Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, Aug. 09, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) investors that a lawsuit filed on behalf of investors that purchased Apellis securities between February 23, 2022 to July 28, 2023, inclusive (the “Class Period”).
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
The lawsuit contends that throughout the designated class period, the Defendants released statements that were materially false or misleading, and they also omitted crucial information. The allegations include:
- The clinical trial design for SYFOVRE was inadequate to detect occurrences of retinal vasculitis among patients who received SYFOVRE injections.
- Consequently, the widespread adoption of SYFOVRE in the commercial market carried substantial, undisclosed risk factors.
- Thus, the statements made by the defendants regarding the Company's business, operations, and future prospects were not reasonably supported and lacked a solid foundation.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com
Attorney Advertising
